Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis

被引：431

作者：

Kuo, Phillip H.

Kanal, Emanuel

Abu-Alfa, Ali K.

Cowper, Shawn E.

机构：

[1] Yale Univ, Sch Med, Dept Diagnost Radiol, New Haven, CT 06520 USA

[2] Yale Univ, Sch Med, Dept Internal Med, Nephrol Sect, New Haven, CT 06520 USA

[3] Yale Univ, Sch Med, Dept Dermatol & Pathol, New Haven, CT 06520 USA

[4] Univ Pittsburgh, Med Ctr, Dept Radiol, Pittsburgh, PA USA

来源：

RADIOLOGY | 2007年 / 242卷 / 03期

关键词：

D O I：

10.1148/radiol.2423061640

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

While at this time there are more questions than answers, the recognition of an epidemiologic association between the administration of gadolinium-based MR contrast agents and the development of nephrogenic systemic fibrosis prompts caution in the use of these agents in the setting of renal disease. © RSNA, 2007.

引用

页码：647 / 649

页数：3

共 50 条

[41] Skin Gadolinium Following Use of MR Contrast Agents in a Rat Model of Nephrogenic Systemic Fibrosis
Haylor, John
Schroeder, Josef
Wagner, Bart
Nutter, Faith
Jestin, Gaelle
Idee, Jean-Marc
Morcos, Sameh
RADIOLOGY, 2012, 263 (01) : 107 - 116
[42] Response to "Will dialysis prevent the development of nephrogenic systemic: Fibrosis after gadolinium-based contrast administration?"
Broome, Dale R.
Cottrell, Alfred C.
Kanal, Emanuel
AMERICAN JOURNAL OF ROENTGENOLOGY, 2007, 189 (04) : W234 - W235
[43] Incidence of Nephrogenic Systemic Fibrosis after Adoption of Restrictive Gadolinium-based Contrast Agent Guidelines
Wang, Yingbing
Alkasab, Tarik K.
Narin, Ozden
Nazarian, Rosalynn M.
Kaewlai, Rathachai
Kay, Jonathan
Abujudeh, Hani H.
RADIOLOGY, 2011, 260 (01) : 105 - 111
[44] Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines
Henrik S. Thomsen
Sameh K. Morcos
Torsten Almén
Marie-France Bellin
Michele Bertolotto
Georg Bongartz
Olivier Clement
Peter Leander
Gertraud Heinz-Peer
Peter Reimer
Fulvio Stacul
Aart van der Molen
Judith AW Webb
European Radiology, 2013, 23 : 307 - 318
[45] Hepatobiliary MR imaging with gadolinium-based contrast agents
Frydrychowicz, Alex
Lubner, Meghan G.
Brown, Jeffrey J.
Merkle, Elmar M.
Nagle, Scott K.
Rofsky, Neil M.
Reeder, Scott B.
JOURNAL OF MAGNETIC RESONANCE IMAGING, 2012, 35 (03) : 492 - 511
[46] Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines
Thomsen, Henrik S.
Morcos, Sameh K.
Almen, Torsten
Bellin, Marie-France
Bertolotto, Michele
Bongartz, Georg
Clement, Olivier
Leander, Peter
Heinz-Peer, Gertraud
Reimer, Peter
Stacul, Fulvio
van der Molen, Aart
Webb, Judith A. W.
EUROPEAN RADIOLOGY, 2013, 23 (02) : 307 - 318
[47] Administration of Gadolinium-Based Contrast Agents in MR Angiography
Lin, Kai
AMERICAN JOURNAL OF ROENTGENOLOGY, 2009, 192 (04) : W193 - W193
[48] Gadolinium-based contrast agents: What we learned from acute adverse events, nephrogenic systemic fibrosis and brain retention
Baeuerle, Tobias
Saake, Marc
Uder, Michael
ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN, 2021, 193 (09): : 1010 - 1018
[49] Recent topics related to nephrogenic systemic fibrosis associated with gadolinium-based contrast agents (vol 19, pg 806, 2012)
Kitajima, K.
Maeda, T.
Watanabe, S.
Ueno, Y.
Sugimura, K.
INTERNATIONAL JOURNAL OF UROLOGY, 2012, 19 (12) : 1127 - 1127
[50] Nephrogenic Systemic Fibrosis in Patients with Chronic Kidney Disease after the Use of Gadolinium-Based Contrast Agents: A Review for the Cardiovascular Imager
Gallo-Bernal, Sebastian
Patino-Jaramillo, Nasly
Calixto, Camilo A.
Higuera, Sergio A.
Forero, Julian F.
Fernandes, Juliano Lara
Gongora, Carlos
Gee, Michael S.
Ghoshhajra, Brian
Medina, Hector M.
DIAGNOSTICS, 2022, 12 (08)

← 1 2 3 4 5 →